The disappearing PI-RADS 5 prostate lesion

Authors

Vikram K. Sabarwal, The George Washington University Hospital
Cayde Ritchie, Loma Linda University School of Medicine
Kareem Rayn, SUNY Downstate Health Sciences University
Baris Turkbey, National Institutes of Health (NIH)
Peter Pinto, National Institutes of Health (NIH)

Document Type

Journal Article

Publication Date

4-1-2018

Journal

Canadian Journal of Urology

Volume

25

Issue

2

Keywords

Assessment tool; PI-RADS; Prostate cancer

Abstract

© The Canadian Journal of Urology™. Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) identifies prostate cancer on the basis of multiparametric MRI (mpMRI). As an assessment tool, it correctly predicts clinically significant cancer in the vast majority of cases. In this light, we report a rare patient, for whom a PI-RADS 5 lesion vanished over the course of 13 months.

APA Citation

Sabarwal, V., Ritchie, C., Rayn, K., Turkbey, B., & Pinto, P. (2018). The disappearing PI-RADS 5 prostate lesion. Canadian Journal of Urology, 25 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_uro_facpubs/522